James H. Brauker, VP Research & Development at DEXCOM INC (DXCM), sold 82,500 shares at $24.00 ($2.0M) on 2006-05-02, disclosed to the SEC on 2006-05-04.
Open-market sale of $2.0M DXCM by VP Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.